• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振体素测量的肿瘤体积减少率与直肠癌术前放化疗的病理肿瘤反应相关。

Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer.

机构信息

Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

出版信息

Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):164-71. doi: 10.1016/j.ijrobp.2009.07.1682. Epub 2009 Dec 11.

DOI:10.1016/j.ijrobp.2009.07.1682
PMID:20004532
Abstract

PURPOSE

To determine whether the tumor volume reduction rate (TVRR) measured using three-dimensional region-of-interest magnetic resonance volumetry correlates with the pathologic tumor response after preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer.

METHODS AND MATERIALS

The study included 405 patients with locally advanced rectal cancer (cT3-T4) who had undergone preoperative CRT and radical proctectomy. The tumor volume was measured using three-dimensional region-of-interest magnetic resonance volumetry before and after CRT but before surgery. We analyzed the correlation between the TVRR and the pathologic tumor response in terms of downstaging and tumor regression grade (TRG). Downstaging was defined as ypStage 0-I (ypT0-T2N0M0), and the TRG proposed by Dworak et al. was used.

RESULTS

The mean TVRR was 65.0% +/- 22.3%. Downstaging and complete regression occurred in 167 (41.2%) and 58 (14.3%) patients, respectively. The TVRRs according to ypT classification (ypT0-T2 vs. ypT3-T4), ypN classification (ypN0 vs. ypN1-N2), downstaging (ypStage 0-I vs. ypStage II-III), good regression (TRG 3-4 vs. TRG 1-2), and complete regression (TRG 4 vs. TRG 1-3) were all significantly different (p <.05). When the TVRR was categorized into three groups (<60%, 60-80%, and >80%), the rates of ypT0-T2, ypN0, downstaging, and good regression were all significantly greater for patients with a TVRR of >or=60%, as was the complete regression rate for patients with a TVRR >80% (p <.05).

CONCLUSION

The TVRR measured using three-dimensional region-of-interest magnetic resonance volumetry correlated significantly with the pathologic tumor response in terms of downstaging and TRG after preoperative CRT for locally advanced rectal cancer.

摘要

目的

确定使用三维感兴趣区磁共振体积测量的肿瘤体积缩小率(TVRR)是否与局部晚期直肠癌术前放化疗(CRT)后的病理肿瘤反应相关。

方法和材料

本研究纳入了 405 例接受术前 CRT 和根治性直肠切除术的局部晚期直肠癌(cT3-T4)患者。在 CRT 前但在手术前使用三维感兴趣区磁共振体积测量法测量肿瘤体积。我们分析了 TVRR 与降期和肿瘤消退分级(TRG)的病理肿瘤反应之间的相关性。降期定义为ypStage 0-I(ypT0-T2N0M0),使用 Dworak 等人提出的 TRG。

结果

平均 TVRR 为 65.0% +/- 22.3%。167 例(41.2%)和 58 例(14.3%)患者发生降期和完全消退。根据 ypT 分类(ypT0-T2 与 ypT3-T4)、ypN 分类(ypN0 与 ypN1-N2)、降期(ypStage 0-I 与 ypStage II-III)、良好消退(TRG 3-4 与 TRG 1-2)和完全消退(TRG 4 与 TRG 1-3)的 TVRR 均有显著差异(p<.05)。当 TVRR 分为三组(<60%、60-80%和>80%)时,TVRR≥60%的患者 ypT0-T2、ypN0、降期和良好消退的比例均显著更高,而 TVRR>80%的患者完全消退的比例也更高(p<.05)。

结论

使用三维感兴趣区磁共振体积测量的 TVRR 与局部晚期直肠癌术前 CRT 后的降期和 TRG 显著相关。

相似文献

1
Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer.磁共振体素测量的肿瘤体积减少率与直肠癌术前放化疗的病理肿瘤反应相关。
Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):164-71. doi: 10.1016/j.ijrobp.2009.07.1682. Epub 2009 Dec 11.
2
Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: the impact of the volume reduction ratio on the prediction of pathologic complete response.术前放化疗后直肠癌患者三维磁共振体积测量评估的肿瘤体积变化:体积减少率对预测病理完全缓解的影响。
Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1018-25. doi: 10.1016/j.ijrobp.2009.03.066. Epub 2009 Aug 3.
3
A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation.一项关于容积分析、组织病理学降期及肿瘤退缩分级在评估局部晚期直肠癌术前放化疗后肿瘤反应中的比较研究。
Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):204-10. doi: 10.1016/j.ijrobp.2006.08.020. Epub 2006 Nov 2.
4
Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.病理性淋巴结分类是术前放化疗和根治性切除治疗的直肠癌患者无病生存的最具鉴别力的预后因素。
Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1158-65. doi: 10.1016/j.ijrobp.2009.06.019. Epub 2009 Sep 30.
5
MRI tumor volume reduction rate vs tumor regression grade in the pre-operative re-staging of locally advanced rectal cancer after chemo-radiotherapy.化疗放疗后局部晚期直肠癌术前再分期中MRI肿瘤体积缩小率与肿瘤消退分级的关系
Eur J Radiol. 2015 Dec;84(12):2438-43. doi: 10.1016/j.ejrad.2015.08.008. Epub 2015 Aug 20.
6
Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer.术前放化疗后肿瘤体积减少率作为局部晚期直肠癌的预后因素。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e193-9. doi: 10.1016/j.ijrobp.2011.03.022. Epub 2011 May 24.
7
Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer?直肠癌术前放化疗后T分期仍与淋巴结状态相关吗?
Cancer. 2006 Apr 15;106(8):1694-700. doi: 10.1002/cncr.21794.
8
Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.T3 期 中 远 端 直 肠 癌 术 前 化 放 疗 的 随 机 、 多 中 心 、 IIb 期 研 究 : 雷 替 曲 塞 + 奥 沙 利 铂 + 放 疗 对 顺 铂 + 5-氟 尿 嘧 啶 + 放 疗
Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):403-12. doi: 10.1016/j.ijrobp.2007.06.025. Epub 2007 Oct 4.
9
The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.直肠癌术前治疗后病理肿瘤退缩分级(TRG)与预后的关系。
Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):752-60. doi: 10.1016/j.ijrobp.2004.11.017.
10
How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?磁共振成像对接受术前同步放化疗的直肠癌患者进行再分期的准确性如何?
Dis Colon Rectum. 2005 Apr;48(4):722-8. doi: 10.1007/s10350-004-0851-1.

引用本文的文献

1
Effectiveness of prognostic nutritional index in predicting overall survival and evaluating immunotherapy response in anaplastic thyroid carcinoma.预后营养指数在预测甲状腺未分化癌患者总生存期和评估免疫治疗反应中的有效性。
Endocrine. 2024 Oct;86(1):246-254. doi: 10.1007/s12020-024-03826-z. Epub 2024 Apr 24.
2
Findings in magnetic resonance imaging for restaging locally advanced rectal cancer.局部进展期直肠癌再分期的磁共振成像表现。
Int J Colorectal Dis. 2024 Jan 30;39(1):23. doi: 10.1007/s00384-024-04595-x.
3
Prognostic Value of Tumor Volume, Tumor Volume Reduction Rate and Magnetic Resonance Tumor Regression Grade in Rectal Cancer.
直肠癌中肿瘤体积、肿瘤体积减少率和磁共振肿瘤退缩分级的预后价值。
Medicina (Kaunas). 2023 Dec 18;59(12):2194. doi: 10.3390/medicina59122194.
4
Semi-Automatic Volumetric and Standard Three-Dimensional Measurements for Primary Tumor Evaluation and Response to Treatment Assessment in Pediatric Rhabdomyosarcoma.半自动容积测量和标准三维测量在儿童横纹肌肉瘤原发肿瘤评估及治疗反应评估中的应用
J Pers Med. 2021 Jul 26;11(8):717. doi: 10.3390/jpm11080717.
5
Neoadjuvant combination of pazopanib or axitinib and programmed cell death protein-1-activated dendritic cell-cytokine-induced killer cells immunotherapy may facilitate surgery in patients with renal cell carcinoma.帕唑帕尼或阿昔替尼与程序性细胞死亡蛋白-1激活的树突状细胞-细胞因子诱导的杀伤细胞免疫疗法的新辅助联合治疗可能有助于肾细胞癌患者的手术。
Transl Androl Urol. 2021 May;10(5):2091-2102. doi: 10.21037/tau-21-406.
6
Characteristics of Patients Presented With Metastases During or After Completion of Chemoradiation Therapy for Locally Advanced Rectal Cancer: A Case Series.局部晚期直肠癌放化疗期间或结束后出现转移的患者特征:病例系列
Ann Coloproctol. 2021 Jun;37(3):186-191. doi: 10.3393/ac.2020.08.10.1. Epub 2020 Sep 18.
7
Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer.根据局部晚期低位直肠癌患者术前化疗反应预测预后。
BMC Cancer. 2019 Dec 16;19(1):1222. doi: 10.1186/s12885-019-6424-4.
8
Optimized Parameters of Diffusion-Weighted MRI for Prediction of the Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.扩散加权 MRI 参数优化预测局部进展期直肠癌新辅助放化疗疗效的研究
Biomed Res Int. 2019 Oct 13;2019:9392747. doi: 10.1155/2019/9392747. eCollection 2019.
9
Early MRI predictors of disease-free survival in locally advanced rectal cancer from the GRECCAR 4 trial.局部进展期直肠癌 GRECCAR 4 试验的无疾病生存早期 MRI 预测因子。
Br J Surg. 2019 Oct;106(11):1530-1541. doi: 10.1002/bjs.11233. Epub 2019 Aug 22.
10
Magnetic resonance imaging in locally advanced rectal cancer: quantitative evaluation of the complete response to neoadjuvant therapy.局部晚期直肠癌的磁共振成像:对新辅助治疗完全缓解的定量评估
Pol J Radiol. 2018 Dec 17;83:e600-e609. doi: 10.5114/pjr.2018.81156. eCollection 2018.